Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS2541804 A
Publication typeGrant
Publication dateFeb 13, 1951
Filing dateJun 20, 1950
Priority dateAug 4, 1949
Publication numberUS 2541804 A, US 2541804A, US-A-2541804, US2541804 A, US2541804A
InventorsWormell Robert L
Original AssigneeCourtaulds Ltd
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Production of artificial protein fibers
US 2541804 A
Abstract  available in
Images(3)
Previous page
Next page
Claims  available in
Description  (OCR text may contain errors)

Patented Feb. 13, 1951 PRODUCTION OF ARTIFICIAL PROTEIN FIBERS Robert L. Wormell, Coventry, England, assignor to Oourtaulds Limited, London, England, a

British company No Drawing. Application June 20, 1950, Serial No. 169,283. In Great Britain August 4, 1949 Claims.

This invention relates to the production of artificial protein fibres.

In the production of fabrics, it is known to form the fabric from a mixture of fibres and subsequently to remove one of the constituent fibres, for example by destroying or dissolving out such fibre; in order to obtain fabrics having special characteristics. Thus, British patent specification No. 547,583 describes tufted yarns for incorporation in a pile fabric comprising yarns made from gelatine, alg'inates, nitrated cellulose, casein or other destructible fibre in admixture with other yarns made for example of cotton fibres; after the tufted yarn has been made into pile fabric the destructible yarn is removed to give a pile fabric having a chenille surface. British patent specification No. 550,525 describes a process for the manufacture of textile fabrics characterised by producing a fabric, at least in part, from yarn consisting wholly or partially of soluble alginic fibres and thereafter modifying the fabric by dissolving or gelatinising some or all of the alginic fibres.

It is the object of the present invention to produce a cheap, soluble, protein fibre having the requisite strength for use in textile processes.

- ,According to the present invention a process for the production of protein fibres soluble in dilute alkaline solutions comprises extruding an 1 alkaline protein solution into a coagulant bath containing one or more metal, salts, stretching the resultant thread at least 50 per cent, rendering the stretched thread resistant to cold water by treatment with an aqueous bath containing halogenated aldehyde, and preferably ,also one or more metal salts, and drying the thus hardened thread, the entire process being effected in the absence of formaldehyde.

The halogen-substituted aldehyde used is preferably chloral, which may be used in the form of its hydrate. Examples of other halogen-substituted aldehydes which may be used are bromal, monochloracetaldehyde, dichloracetaldehyde and water-soluble halogen-substituted propionaldehydes such I as 1 l-dibromopropionaldehyde.

The protein used in the process of the present invention may be animal casein, otherwise known as lactic casein, or vegetable protein, otherwise known as vegetable casein, for example soya bean protein, peanut protein or castor bean protein.

The coagulant bath used in the process according to the invention contains one or more metal salts suitable for coagulating the protein, for example sodium sulphate, magnesium sulphate, aluminium sulphate or sodium chloride; mixtures of such salts may also be used. An acid such as sulphuric acid may also be included in the coagulant bath. The coagulant bath may be used at ordinary temperatures, namely about 15 to 25 centigrade, or may ,be used at elevated temperatures, for example at 35 to 40 centigrade.

The stretching according to the invention may be effected by means of stretching rollers, reels or godets. The stretching is preferably effected in the presence of a coagulant bath, for example by using rollers immersed in the coagulant bath or preferably by using rollers in a subsequent coagulating bath which may be the same as or different from the coagulant bath; the stretching may be effected outside the coagulant bath by leading the thread on withdrawal from the bath to stretching rollers by suitably placed guides. The coagulant baths in which stretching is effected are preferably heated for example to 40 to centigrade; if desired two or more baths of increasing temperatures may be used. The stretching should be at least 50 per cent but is preferably much higher for example from 300- 700 per cent.

In accordance with the present invention, the fibres may be partially hardened with chloral or the like before they are stretched and the hardening is then completed in a subsequent chloral or like bath. For example, chloral may be added to the coagulant bath, to the subsequent coagulant liquid baths in which the stretching takes place or to both these baths.

The treatment with chloral or similar halogensubstituted aldehyde according to the invention to render the stretched threads resistant to cold water may be effected by passing the threads through an aqueous bath of chloral or the like for example by means of rollers or thread advancing reels, or may be effected by allowing the fibers to accumulate in a relaxed condition within an aqueous bath containing chloral or the like. In this latter form of the invention, the treatment is preferably effected by the method described in U. S. Patent No. 2,383,358, which corresponds to British specification No. 565,011. The aqueous chloral or like bath preferably also contains one or more metal salts such as for example sodium sulphate, magnesium sulphate, aluminium acetate, calcium chloride or mixtures of such salts, to assist in the hardening of the thread. The thread may also be stretched further after the treatment with the halogen-substituted aldehyde. The chloral or the like hardening bath may also be heated if desired, for example from 40 to 70 centigrade.

The fibres obtained according to the present invention generally have dry tenacities oif from i to 2 grams per denier and are thus suitable for use either as warp or weft in the normal textile processes such as knitting and weaving. The ilbres, however, when place in weak alkaline solution such as a dilute ammonia-soap bath readily swell and become dispersed in the alkaline solution. This, action normally takes place within a few minutes at room temperature and may be speeded up by warming the alkaline solution. The fibres are therefore particularly suitable for use as a soluble yarn in the production of eflect textile materials; for example the fibre may be used as a binder for twistless yarns or may be twisted with wool fibres to produce yarns for making fabrics which on removal of the protein fibre give worsted fabrics with very fine yarns normally incapable of being woven or knitted. When used in conjunction with wool fibres the protein fibres according to the invention are readily removed from the fabric by the normal scouring process.

The invention is illustrated by the following examples, in which the percentages are by weight; weights of sodium sulphate are based on the anhydrous salt, NazSOr:

Example i A solution. containing" so per cent of peanut protein, 0.45 per cent of caustic soda and 0.33 per cent of sodium sulphide was extruded into a bath maintained at 20 centigrade and containing soc grams of crystalline aluminium sulphate (AMSUQ 3.18Hz) per litre. The extruded threads were withdrawn from the bath and stretched coo per cent in a similar bath but heated to a temperature of 60 centigrade. The threads were then placed in the relaxed condition in a bath containing, in each litre, 150 grams of sodium sulphate,- 450 grams of crystalline magnesium sulphate (MgSO4'IH2O), and 31 grams of chloral hydrate. The threads were kept in this bath, maintained at a temperature of 40 centigrade and a pH of 7.0 for 7 hours, and were then washed with water, stretched 200 per cent in water and dried under tension.

The threads obtained had a dry tenacity of 1.6 grams per denier and were soluble in a bath containing in each litre 4c grams of ammonia and 10 grams of sodium stearate.

Example 2 Threads were extruded, stretched and treated exactly as described in Example 1 except that they were left in the chloral hydrate solution for only 2 hours at 38 cenigrade. Th finally dried threads were found to be soluble in a bath containing in each litre 10 grams of sodium carbonate (soda ash) and 10 grams of sodium oleate.

Example 3 A solution containing 20 per cent of peanut protein, 0.45 per cent of caustic soda and 0.33

"litre, 150 grams or soluble in a bath containing in each litre 40 grams anhydrous sodium sulphate. 450 grams of crystalline magnesium sulphate and 10 grams of chloral hydrate. The threads were kept in this bath, maintained at a temperature of 40 centigrade and a pH 0! 7.0 for 16 hours, and were then washedwith water and dried. The threads obtained were soluble in a bath con-- taining in each litre 40 grams or ammonia and 10 grams of sodium stearate.

Example 4 The procedure described in Example 3 was repeated using a 20 per cent solution of lactic casein in 1.0 per cent aqueous caustic soda in place or the peanut protein solution. The product was a lactic casein fibre which was soluble in a, bath containing in each litre 40 grams of ammonia and 10 grams of sodium stearate.

Example 5 The procedure described in Example 3 was repeated with the only exception that the peanut protein solution was extruded into a bath maintained at 35 centigrade and containing in each litre, 400 grams of sodium sulphate and 10 grams of sulphuric acid. The threads obtained were of ammonia and 10 grams of sodium stearate.

A similar coagulant bath may also be used in Example 4 to give a similar alkali-soluble lactic casein fibre.

Example c The procedure described in Example 3 was re peated with the only exception that the peanut protein solution was extruded into a bath maintained at 35 centigrade and containing in each litre, 400 grams of sodium sulphate, 10 grams of sulphuric acid and 12 grams of chloral hydrate. The threads obtained were soluble in a bath containing in each litre 40 grams of ammonia and 10 grams of sodium stearate.

Erample 7 The procedure described in Example 3 was repeated with the only exception that the peanut protein solution was extruded into a coagulant bath at 25 centigrade containing in each litre. grams of sodium sulphate, 450 grams of crystalline magnesium sulphate and 10 grams of sulphuric acid. The threads obtained were soluble in. a bath containing in each litre 40 grams of ammonia and 10 grams of sodium stearate.

Example 8 A solution containing 20 per cent of peanut protein, 0.45 per cent of caustic soda and 0.33 per cent of sodium sulphide was extruded into a bath maintained at 25 centigrade and containing in each litre, 150 grams of sodium sulphate. 450 grams of crystalline magnesium sulphate and 10 grams of sulphuric acid. The extruded threads were withdrawn from the bath and stretched 600 per cent by first stretchin the threads 350 per cent in a bath at 40 centigrade containing in each litre, 500 grams of crystalline aluminium sulphate and 15 grams of chloral hydrate and then completing the stretching in a similar bath at 70 centigrade. The threads were then placed in the relaxed condition in a bath containing in each litre, 150 grams of anhydrous sodium sulphate, 450 grams of crystalline magnesium sulphate and 10 grams of chloral hydrate. The threads were kept in this bath, mainpH of 7.0 for 16 hours, and were then washed with water and dried. The threads obtained were soluble in a bath containing in each litre 40 grams of ammonia and grams of sodium stearate.

Example 9- A solution containing 20 per cent of peanut protein, 0.45 per cent of caustic soda and 0.33 per cent of sodium sulphide was extruded into a bath maintained at 25 centigrade and containing in each litre, 150 grams of sodium sulphate, 450 grams of crystalline magnesium sulphate and 10 grams of sulphuric acid; The extruded threads were withdrawn from the bath and stretched 600 per cent by first stretching the threads 350 per cent in a bath at 40 centigrade containing in each litre, 500grams of crystalline aluminum sulphate and grams of chloral hydrate and then completing the stretching in a similar bath at 70 centigrade. The threads were then collected in cake form in a rapidly rotating centrifugal box. The threads were hardened further in cake form by circulating through the cakes a. bath containing in each litre, 150 grams of sodium sulphate, 450 grams of crystalline magnesium sulphate and 10 grams of chloral hydrate. The threads were then washed with water, dried and rewound onto bobbins as twisted threads. The twisted threads were then stretched 100 per cent at 50 centigrade in anaqueous chloral solution containing 5 grams oi chloral hydrate per litre. The threads were washed with acetone and dried under tension. The threads obtained were soluble in a bath containing in each litre 40 grams or ammonia and 10 grams of sodium stearate. v

What I claim is:

1. A process for the production of protein fibres soluble in dilute alkaline solutions comprising extruding an alkaline protein solution into a coagulant b'ath containing at least one metal salt to coagulate the protein, stretching the resultant 'thread at least 50 per cent, rendering the stretched thread resistant to cold water by treatment with an aqueous bath-containing chloral and drying the thus hardened thread, the entire process being effected in the absence of formaldehyde.

2. A process for the production of protein fibres soluble in dilute alkaline solutions comprising extruding an alkaline protein solution into a coagulant bath containing at least one metal salt to coagulate the protein, stretching the resultant thread at least per cent, rendering the stretched thread resistant to cold water by treatment with an aqueous bath containing chloral and at least one metal salt to assist in hardening the thread and drying the thus hardened thread, the entire process being effected in the absence of formaldehyde.

3. A process for the production of protein fibres soluble in dilute alkaline solutions comprising extruding an alkaline protein solution into a coagulant bath containing at least one metal salt to coagulate the protein. stretching the resultant thread at least 50 per cent in the coagulant bath, rendering the stretched thread resistant to cold water by treatment with an aqueous bath containing chloral and drying the thus hardened thread, the entire process being effected in the absence of iormaldehyde.

4. A process for the production of protein fibres soluble in dilute alkaline solutions comprising extruding an alkaline protein solution into a coagulant bath containing at least one metal salt to coagulate the protein, stretching the resultant thread at least 50 per cent in a subsequent bath containing at least one metal salt, rendering the stretched thread resistant to cold water by treatment with an aqueous bath containing chloral and drying the thus hardened thread, the entire process being efiected in the absence of formaldehyde.

5.- A process for the production of protein fibres soluble in dilute alkaline solutions comprising extruding an alkaline protein solution into a coagulant bath containing at least one metal salt to coagulate the protein, stretching the resultant thread from 300 to 700 per cent. rendering the stretched thread resistant to cold water by treatmentwith an aqueous bath containing chloral and drying the thus hardened thread. the entire process being eflected in the absence of formaldehyde.

l1. L. WORMELL.

No references cited.

Non-Patent Citations
Reference
1 *None
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US4562110 *Aug 17, 1982Dec 31, 1985Tong David PhilipProcess for the production of alginate fibre material and products made therefrom
US5650116 *Mar 18, 1996Jul 22, 1997Hercules IncorporatedMethod of making a medical device from ironically crosslinked polymer
US5820608 *Mar 18, 1996Oct 13, 1998Hercules IncorporatedMethod for in vivo chemically triggered disintegration of medical device
US6126645 *Mar 18, 1996Oct 3, 2000Scimed Life Systems, Inc.Medical devices subject to triggered disintegration
US6368356Feb 25, 2000Apr 9, 2002Scimed Life Systems, Inc.Medical devices comprising hydrogel polymers having improved mechanical properties
US6387978Jan 8, 2001May 14, 2002Boston Scientific CorporationMedical devices comprising ionically and non-ionically crosslinked polymer hydrogels having improved mechanical properties
US6823569 *Jun 28, 2001Nov 30, 2004Polgat Textiles Co.Process for the manufacture of super fine woven wool fabric with single yarn in the warp having improved weavability
US6913765Mar 21, 2001Jul 5, 2005Scimed Life Systems, Inc.Controlling resorption of bioresorbable medical implant material
US7335375Jun 21, 2005Feb 26, 2008Boston Scientific Scimed, Inc.Controlling resorption of bioresorbable medical implant material
US7910125Feb 26, 2008Mar 22, 2011Boston Scientific Scimed, Inc.Controlling resorption of bioresorbable medical implant material
US8318195Dec 3, 2010Nov 27, 2012Boston Scientific Scimed, Inc.Controlling resorption of bioresorbable medical implant material by application of microwave, ultrasound or radiofrequencies
US8545869Nov 26, 2012Oct 1, 2013Boston Scientific Scimed, Inc.Controlling resorption of bioresorbable medical implant material through dispersed responsive particles
US20020133924 *Jun 28, 2001Sep 26, 2002Yacov CohenNovel process for the manufacture of super fine woven wool fabric with single yarn in the warp having improved weavability
US20050238690 *Jun 21, 2005Oct 27, 2005Jianmin LiControlling resorption of bioresorbable medical implant material
US20080152692 *Feb 26, 2008Jun 26, 2008Boston Scientific Scimed, Inc.Controlling resorption of bioresorbable medical implant material
US20110091519 *Dec 3, 2010Apr 21, 2011Boston Scientific Scimed, Inc.Controlling resorption of bioresorbable medical implant material
USRE38158Nov 4, 1998Jun 24, 2003Minnesota Mining And Manufacturing CompanyAdhesive sealant composition
USRE38827Nov 14, 2002Oct 11, 20053M Innovative Properties CompanyAdhesive sealant composition
Classifications
U.S. Classification264/202, 28/168, 8/127.6
International ClassificationD01F4/00
Cooperative ClassificationD01F4/00
European ClassificationD01F4/00